Mylan Plaintiffs Make New Bid For Treble Damages

Law360, New York (November 5, 2007, 12:00 AM EST) -- In its long-running antitrust litigation against Mylan Laboratories over two of the generic drug maker's anti-anxiety drugs, Blue Cross Blue Shield of Massachusetts has renewed its effort to push the court to triple damages against Mylan and two drug ingredient supplier defendants, citing details from a separate case.

In court documents filed Wednesday in the U.S. District Court for the District of Columbia, BCBS Massachusetts contends that a separate malpractice suit Mylan brought against its former antitrust counsel Eliot G. Disner, provides key information that supports...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.